Speaker illustration

Professor Seppo Yla-Herttuala

A.I. Virtanen Institute for Molecular Sciences, Kuopio (Finland)

Gene therapy for lipid disorders

Event: ESC CONGRESS 2019

Topic: Pharmacology and Pharmacotherapy

Session: Frontiers in cardiovascular therapeutics

Thumbnail

Genome editing for treatment of atherosclerosis

Event: ESC CONGRESS 2019

Topic: Basic Science

Session: Genome editing for heart disease.

Thumbnail

AdVEGF-D induces functional angiogenesis and lymphangiogenesis in ischemic heart

Event: ESC Congress 2018

Topic: Treatment, Other

Session: Coronary artery disease: diagnosis, pharmacotherapy and revascularisation

Thumbnail

Optimizing reproducibility in gene therapy.

Event: ESC Congress 2018

Topic: Basic Science

Session: Lost in translation: the crisis of reproducibility in pre-clinical cardiovascular research

Thumbnail

DNA-methylation profiles in human atherosclerosis.

Event: ESC CONGRESS 2016

Topic: Vascular biology, other

Session: Epigenetic modulation of cardiovascular disease

Thumbnail

This platform is supported by

logo Novo Nordisk